Buscar | WebWorks Co. Community

agregó una foto Health

2026-07-06 12:13:33 -

Biologic Therapies Fueling the Dupixent Market Growth

The growing prevalence of chronic inflammatory diseases has accelerated demand for targeted biologic therapies that offer improved efficacy and long-term disease control. Among these therapies, Dupixent (dupilumab) has become one of the leading biologic treatments for multiple type 2 inflammatory diseases. The rapid dupilumab market growth, continued expansion of the biologics market, and...

0 Commentarios 0 Acciones 8 Views 0 Vista previa